Niimbl research, development, and testbeds to help the nation prevent, prepare for, and respond to coronavirus

Ended Cooperative Agreement Awarded Last action

Award ID
70NANB21H085
Recipient
Awarding agency
Obligated
$83,000,000

Award facts

Completion date
Originally
Place of performance
Newark, DE 19716, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment Support research, development, and testbeds to help the nation prevent, prepare for, and respond to coronavirus. $0
Original award $83,000,000

Subawards

Subrecipient Amount Awarded
Caring Cross Inc. Open-Source Lentiviral Vector and Adenoviral-Associated Viral Vector Manufacturing Platforms $4,356,280
Montgomery County Community College Developing Directive Documents for Adoption of the NISTCHO Cell Line in Biomanufacturing Workforce Training $140,472
Montgomery College $221,874
Massachusetts Institute Of Technology Accelerating the manufacture and scale up of virus-like particle vaccines. $1,379,500
Texas A&M Engineering Experiment Station Developing Testbeds for Biopharmaceutical Manufacturing Workforce Development in Louisiana, North Carolina, Maryland, Delaware, and Texas. $1,245,626
Xavier University Of Louisiana Establishing Testbeds for Biopharmaceutical Manufacturing Workforce Development in Louisiana, North Carolina, Maryland, Delaware, and Texas $999,508
University Of Maryland Baltimore County $912,123
North Carolina Central University $625,614
University Of Massachusetts Lowell Rapid Continuous Production of Room Temperature Stable mRNA Vaccines: mRNA Producing Machine $437,217
Sepragen Corp $530,769
Rensselaer Polytechnic Institute LNP-mRNA Vaccine Stability: Reference Materials, Rapid Stability Assessment and Lyophilized Formulation Development $580,219
Carnegie-Mellon University $311,042
Physical Sciences Inc. Develop User Requirement Specification Document (URS) that will outline the commercial requirements that will guide vaccine formulation development. $328,327
University Of Massachusetts Lowell Analyze unformulated vaccine drug substance to determine thermal properties pre-formulation. $379,296
National Institute For Pharmaceutical Technology & Education Inc. Develop User Requirement Specification Document (URS) that will outline the commercial requirements that will guide vaccine formulation development. $222,600
Texas A&M Engineering Experiment Station Rapid Single-use PCR-based Nucleic Acid Testing $750,000
Purdue University Advanced Characterization and Manufacturing Methods for mRNA Vaccine Development $473,733
Carnegie-Mellon University Deliverables include verifiable products, results, and/or capabilities that serve as the outcome of the execution of work. Level 3 further breaks down the… $344,085
Rensselaer Polytechnic Institute Continuous Purification for mRNA Vaccine Production: Replacing Chromatography with Adsorptive Membranes $724,297
Path Thermostable formulations of NDV-HXP-S COVID vaccine 1.0. Identification of two or more thermostable multidose liquid formulation of NDV-HXP-S coronavirus… $340,364
North Carolina State University This proposal is to establish 1) an mRNA vaccine technology testbed for: (a) process innovation and development, (b) product characterization, and (c) workforce… $913,215
University Of Massachusetts Medical School Deliverables include verifiable products, results, and/or capabilities that serve as the outcome of the execution of work. Level 3 further breaks down the… $284,887
Health Research, Inc. Deliverables include verifiable products, results, and/or capabilities that serve as the outcome of the execution of work. • Level 3 further breaks down… $285,059
Accugenomics, Inc. Deliverables include verifiable products, results, and/or capabilities that serve as the outcome of the execution of work. • Level 3 further breaks down… $415,391
Fraunhofer Usa, Inc. Development Of Scalable, Thermostable, Spray Dried Vaccine Formulations Applicable For Coronavirus Vaccines. $565,728
Massachusetts Institute Of Technology Monoclonal antibody expression in fast alternative host: Demonstration & Reference Material. $462,301
University Of Maryland, Baltimore Noninvasive detection of counterfeit and substandard vaccines and biotherapeutics. $600,047
Sentrysciences, Inc. Evaluation of an automated vapor phase hydrogen peroxide decontamination system for rapid, non-residual decontamination of clinical spaces. $40,420
EMD Millipore Corp Development of a CHO-based upstream process for rapid production of coronavirus antigen variants $285,680
University Of Maryland, College Park A Bioelectronic Sensor for Rapid Assessment of Antibody Titer and Glycan Structure. $293,550
Cecil College Supporting Pharmaceutical and Bioproduction Manufacturing with a Certificate in Laboratory Techniques to Provide an Entry-Level Workforce $106,471
University Of Missouri System Pandemic Preparedness and Response (PPRP) - A Three-Fold Process $195,586
North Carolina State University A New Generation of High�efficiency HVAC Filters That Can be used with Existing Infrastructure to Stop the Spread of Coronavirus through Recirculation of… $554,535
Show all 33

Quick answers

Who received award 70NANB21H085?

70NANB21H085 was awarded to University Of Delaware by National Institute of Standards and Technology (Department of Commerce) on July 13, 2021.

How much is award 70NANB21H085 worth?

$83,000,000 has been obligated on 70NANB21H085.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login